Exhale

The official blog of the Lung Institute.

This Week in Lung Disease: New Lung Scanning in Development

19 Aug 2016
| Under Lifestyle | Posted by
| 4 Comments
This Week in Lung Disease

For those having trouble finding interesting news affecting those with lung disease, have no fear. Each week, the Lung Institute searches the internet to find the latest lung disease news, so you can focus on your family and health.

Researchers Studying New Lung Disease Scanning Technology to Help Patients

Lung Disease researchers are looking into how to see the lungs in high definition.

The four-dimensional lung scanning program is designed to offer higher resolution scans of the lung tissue. This will allow researchers and medical professionals better insights and improved treatment options. This technology was developed by researchers at Monash University in Australia and commercialized by the 4Dx company.

For more information, check out the Lung Disease News website.

Olympians Offer Tips on Better Sleep

All eyes are on the athletes in Brazil as the 2016 Summer Olympic Games continue in Rio de Janeiro.

As the world watches these athletes during warm-ups and competitions, we don’t get to see how they handle one crucial area of their preparation – sleep. Sleep to athletes is one of the most important parts of their training, because a well-rested body can lead to better performance during the day. This also applies for people with chronic lung disease.

Check out the tips from U.S. gymnast Gabby Douglas, U.S. rower Sam Ojserkis and more at The Huffington Post.

Experiment Finds Dopamine Levels Bounce Back After Quitting Smoking

A small-scale experiment is offering some good news to those who are trying to quit.

For people who smoke, the brain produces less dopamine – a chemical associated with pleasure and addiction. But according to this experiment conducted by a researcher from Lubeck University in Germany, dopamine deficiency can be reversed when smokers give up the habit. Researchers looked at 15 people who never smoked and 30 people who are smokers.

The smokers were offered smoking cessation treatments and did brain scans at the start and three months later. The never smokers only received brain scans. At the start, the smokers had a 15-20 percent lower production levels of dopamine versus nonsmokers. After three months, there was no difference in dopamine levels between smokers and nonsmokers.

For more information, check out the article on Fox News.

Coal Mining Ends in a Fertile Farming Area of Australia

Farmers, environmentalists and politicians are celebrating what looks to be a major victory in the fight against coal mining in New South Wales, Australia.

The New South Wales government announced the enormous Shenhua Watermark Coalmine will be stopping operation in the fertile farming region of the Liverpool Planes. Politicians and environmentalists feared continued mining in that region would bring great risks to the local environment and the people of Australia.

Coalmining is linked to pneumoconiosis, also known as Black Lung Disease.

Read more on The Guardian.

Keep checking in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in cellular therapys for those with lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or cellular therapy, please contact one of our patient coordinators by calling 888-745-6697 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.